1887

Abstract

As with human cytomegalovirus (HCMV) infection of humans, murine CMV (MCMV) infection is widespread in its natural host, the house mouse , and may consist of mixed infection with different CMV isolates. The incidence and mechanisms by which mixed infection occurs in free-living mice are unknown. This study used two approaches to determine whether mixed infection with MCMV could be established in laboratory mice. The first utilized two naturally occurring MCMV strains, N1 and G4, into which the gene was inserted by homologous recombination. The gene was used to track recombinant and parental viruses in simultaneously coinfected mice. In the second approach, a real-time quantitative PCR (qPCR) assay was used to detect viral immediate-early 1 () gene sequences in mice successively coinfected with G4 and then with the K181 MCMV strain. In both systems, mixed infection was detected in the salivary glands and lungs of experimentally infected mice. MCMV-specific antibody in sera and G4 IE1-specific cytotoxic lymphocyte responses in the spleens of twice-infected mice did not prevent reinfection. Finally, the prevalence of mixed infection in free-living mice trapped in four Australian locations was investigated using real-time qPCR to detect DNA sequences of N1, G4 and K181. Mixed infection with MCMVs containing the G4 and K181 sequences was detected in the salivary glands of 34·2 % of trapped mice. The observations that mixed infections are common in free-living and are acquired by immunocompetent mice through simultaneous or successive infections are important for vaccine development.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81583-0
2006-05-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/5/1123.html?itemId=/content/journal/jgv/10.1099/vir.0.81583-0&mimeType=html&fmt=ahah

References

  1. Adler S. P., Starr S. E., Plotkin S. A., Hempfling S. H., Buis J., Manning M. L., Best A. M. 1995; Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 171:26–32 [CrossRef]
    [Google Scholar]
  2. Allan J. E., Shellam G. R. 1984; Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch Virol 81:139–150 [CrossRef]
    [Google Scholar]
  3. Arav-Boger R., Willoughby R. E., Pass R. F., Zong J. C., Jang W. J., Alcendor D., Hayward G. S. 2002; Polymorphisms of the cytomegalovirus (CMV)-encoded tumour necrosis factor- α and β -chemokine receptors in congenital CMV disease. J Infect Dis 186:1057–1064 [CrossRef]
    [Google Scholar]
  4. Balthesen M., Messerle M., Reddehase M. J. 1993; Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 67:5360–5366
    [Google Scholar]
  5. Booth T. W., Scalzo A. A., Carrello C., Lyons P. A., Farrell H. E., Singleton G. R., Shellam G. R. 1993; Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch Virol 132:209–220 [CrossRef]
    [Google Scholar]
  6. Britt W. J., Alford C. A. 1996; Cytomegalovirus. In Field's Virology , 3rd edn. pp  2221–2230 Edited by Field B., Knipe D., Howley P. Philadelphia: Lippincott-Raven;
    [Google Scholar]
  7. Bunde T., Kirchner A., Hoffmeister B. & 8 other authors 2005; Protection form cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201:1031–1036 [CrossRef]
    [Google Scholar]
  8. Cardin R. D., Abenes G. B., Stoddart C. A., Mocarski E. S. 1995; Murine cytomegalovirus IE2, an activator of gene expression, is dispensable of growth and latency in mice. Virology 209:236–241 [CrossRef]
    [Google Scholar]
  9. Chalmer J. E., Mackenzie J. S., Stanley N. F. 1977; Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 37:107–114 [CrossRef]
    [Google Scholar]
  10. Chandler S. H., Handsfield H. H., McDougall J. K. 1987; Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease. J Infect Dis 155:655–660 [CrossRef]
    [Google Scholar]
  11. Chou S. W. 1986; Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N Engl J Med 314:1418–1423 [CrossRef]
    [Google Scholar]
  12. Cicin-Sain L., Podlech J., Messerle M., Reddehase M. J., Koszinowski U. H. 2005; Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol 79:9492–9502 [CrossRef]
    [Google Scholar]
  13. Coaquette A., Bourgeois A., Dirand C., Varin A., Chen W., Herbein G. 2004; Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 39:155–161 [CrossRef]
    [Google Scholar]
  14. Del Val M., Volkmer H., Rothbard J. B., Jonjic S., Messerle M., Schickedanz J., Reddehase M. J., Koszinowski U. H. 1988; Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J Virol 62:3965–3972
    [Google Scholar]
  15. Drew W. L., Sweet E. S., Miner R. C., Mocarski E. S. 1984; Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis 150:952–953 [CrossRef]
    [Google Scholar]
  16. Farroway L. N., Singleton G. R., Lawson M. A., Jones D. A. 2002; The impact of murine cytomegalovirus (MCMV) on enclosure populations of house mice ( Mus domesticus ). Wildl Res 29:11–17 [CrossRef]
    [Google Scholar]
  17. Farroway L. N., Gorman S., Lawson M. A., Harvey N. L., Jones D. A., Shellam G. R., Singleton G. R. 2005; Transmission of two Australian strains of murine cytomegalovirus (MCMV) in enclosure populations of house mice ( Mus domesticus ). Epidemiol Infect 133:701–710 [CrossRef]
    [Google Scholar]
  18. Fowler K. N., Stagno S., Pass R. F. 2003; Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289:1008–1011 [CrossRef]
    [Google Scholar]
  19. Gardner M. B., Officer J. E., Parker J., Estes J. D., Rongey R. W. 1974; Induction of disseminated virulent cytomegalovirus infection by immunosuppression of naturally chronically infected wild mice. Infect Immun 10:966–969
    [Google Scholar]
  20. Gerna G., Baldanti F., Zavattoni M., Sarasini A., Percivalle E., Revello M. G. 1992; Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antiviral Res 19:333–345 [CrossRef]
    [Google Scholar]
  21. Grzimek K., Podlech A. J., Steffens H.-P., Holtappels R., Schmalz S., Reddehase M. J. 1999; In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus. J Virol 73:5043–5055
    [Google Scholar]
  22. Henson D., Neapolitan C. 1970; Pathogenesis of chronic mouse cytomegalovirus infection in submaxillary glands of C3H mice. Am J Pathol 58:255–267
    [Google Scholar]
  23. Huang E. S., Alford C. A., Reynolds D. W., Stagno S., Pass R. F. 1980; Molecular epidemiology of cytomegalovirus infections in women and their infants. N Engl J Med 303:958–962 [CrossRef]
    [Google Scholar]
  24. Hudson J. B. 1988; Further studies on the mechanism of centrifugal enhancement of cytomegalovirus infectivity. J Virol Methods 19:97–108 [CrossRef]
    [Google Scholar]
  25. Jacob J., Ylönen H., Hodkinson C. G. 2002; Trapping efficiency of Ugglan traps and Longworth traps for house mice in south-eastern Australia. Wildl Res 29:101–103 [CrossRef]
    [Google Scholar]
  26. Keil G. M., Ebeling-Keil A., Koszinowski U. H. 1987; Immediate-early genes of murine cytomegalovirus: location, transcripts and translation products. J Virol 61:526–533
    [Google Scholar]
  27. Kim K. S., Carp R. I. 1971; Growth of murine cytomegalovirus in various cell lines. J Virol 7:720–725
    [Google Scholar]
  28. Kurz S., Steffens H. P., Mayer A., Harris J. R., Reddehase M. J. 1997; Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980–2987
    [Google Scholar]
  29. Lawson C. M., Grundy J. E., Shellam G. R. 1988; Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J Gen Virol 69:1987–1998 [CrossRef]
    [Google Scholar]
  30. Lutarewych M. A., Quirk M. R., Kringstad B. A., Li W., Verfaillie C. M., Jordan M. C. 1997; Propagation and titration of murine cytomegalovirus in a continuous bone marrow-derived stromal cell line (M2-10B4). J Virol Methods 68:193–198 [CrossRef]
    [Google Scholar]
  31. Lyons P. A., Allan J. E., Carrello C., Shellam G. R., Scalzo A. A. 1996; Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1 -encoded pp89 on T cell recognition. J Gen Virol 77:2615–2623 [CrossRef]
    [Google Scholar]
  32. Manning W. C., Mocarski E. S. 1988; Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene ( ie2 ) is dispensable for growth. Virology 167:477–484
    [Google Scholar]
  33. Manning W. C., Stoddart C. A., Lagenaur L. A., Abenes G. B., Mocarski E. B. 1992; Cytomegalovirus determinant of replication in the salivary glands. J Virol 66:3794–3802
    [Google Scholar]
  34. Mannini A., Medearis D. N. Jr 1961; Mouse salivary gland virus infections. Am J Hyg 73:329–343
    [Google Scholar]
  35. Meyer-König U., Ebert K., Schrage B., Pollak S., Hufert F. T. 1998; Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352:1280–1281
    [Google Scholar]
  36. Misra V., Hudson J. B. 1980; Minor base differences between the genomes of two strains of murine cytomegalovirus differing in virulence. Arch Virol 64:1–8 [CrossRef]
    [Google Scholar]
  37. Mocarski E. S. Jr, Kemble G. W. 1996; Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology 39:320–330
    [Google Scholar]
  38. Morley P. J., Ertl P. F., Sweet C. 2003; High-frequency interferon- γ -secreting splenocytes specific for murine cytomegalovirus immediate-early-1 (IE-1) peptide 168YPHFMPTNL176 are insufficient to provide complete protection from viral challenge. J Med Virol 69:240–250 [CrossRef]
    [Google Scholar]
  39. Moro D., Lloyd M. L., Smith A. L., Shellam G. R., Lawson M. A. 1999; Murine viruses in an island population of introduced house mice and endemic short-tailed mice in Western Australia. J Wildl Dis 35:301–310 [CrossRef]
    [Google Scholar]
  40. Moro D., Lawson M. A., Hobbs R. P., Thompson R. C. A. 2003; Pathogens of house mice on arid Boullanger Island and subantarctic Macquarie Island, Australia. J Wildl Dis 39:762–771 [CrossRef]
    [Google Scholar]
  41. Osborn J. E. 1981; Cytomegalovirus and other herpesviruses. In The Mouse in Biomedical Research pp  267–292 Edited by Foster H. L., Small J. D., Fox J. G. New York: Academic Press;
    [Google Scholar]
  42. Pahl-Seibert M.-F., Jeulch M., Podlech J., Thomas D., Deegen P., Reddehase M. J., Holtappels R. 2005; Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. J Virol 79:5400–5413 [CrossRef]
    [Google Scholar]
  43. Plotkin S. A., Starr S. E., Friedman H. M., Gonczol E., Weibel R. E. 1989; Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis 159:860–865 [CrossRef]
    [Google Scholar]
  44. Plummer G. 1973; Cytomegaloviruses of man and animals. Prog Med Virol 15:92–125
    [Google Scholar]
  45. Reddehase M. J., Keil G. M., Koszinowski U. H. 1984; The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. J Immunol 132:482–489
    [Google Scholar]
  46. Reddehase M. J., Mutter W., Munch K., Buhring H. J., Koszinowski U. H. 1987; CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 61:3102–3108
    [Google Scholar]
  47. Reddehase M. J., Jonjic S., Weiland F., Mutter W., Koszinowski U. H. 1988; Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised hose: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J Virol 62:1061–1065
    [Google Scholar]
  48. Reddehase M. J., Rothbard J. B., Koszinowski U. H. 1989; A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337:651–653 [CrossRef]
    [Google Scholar]
  49. Saederup N., Lin Y. C., Dairaghi D. J., Schall T. J., Mocarski E. S. 1999; Cytomegalovirus-encoded β chemokine promotes monocyte-associated viraemia in the host. Proc Natl Acad Sci U S A 96:10881–10886 [CrossRef]
    [Google Scholar]
  50. Shen C. Y., Chang S. F., Chao M. F. & 8 other authors 1993; Cytomegalovirus recurrence in seropositive pregnant women attending obstestric clinics. J Med Virol 41:24–29 [CrossRef]
    [Google Scholar]
  51. Singh N., Wannstedt C., Keyes L., Wagener M. M., Cacciarelli T. V. 2005; Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?. Liver Transpl 11:700–704 [CrossRef]
    [Google Scholar]
  52. Singleton G. R., Smith A. L., Shellam G. R., Fitzgerald N., Muller W. J. 1993; Prevalence of viral antibodies and helminths in field populations of house mice ( Mus domesticus ) in southeastern Australia. Epidemiol Infect 110:399–417 [CrossRef]
    [Google Scholar]
  53. Sissons J. G., Carmichael A. J. 2002; Clinical aspects and management of cytomegalovirus infection. J Infect 44:78–83 [CrossRef]
    [Google Scholar]
  54. Smith A. L., Singleton G. R., Hansen G. M., Shellam G. 1993; A serologic survey for viruses and Mycoplasma pulmonis among wild house mice ( Mus domesticus ) in southeastern Australia. J Wildl Dis 29:219–229 [CrossRef]
    [Google Scholar]
  55. Spector S. A., Hirata K. K., Newman T. R. 1984; Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome. J Infect Dis 150:953–956 [CrossRef]
    [Google Scholar]
  56. Teo H. K., Price P., Papadimitriou J. M. 1991; The effects of protein malnutrition on the pathogenesis of murine cytomegalovirus disease. Int J Exp Pathol 72:67–82
    [Google Scholar]
  57. van Regenmortel M. H. V., Fauquet C. M., Bishop D. H. L. 2000; Virus Taxonomy: Classification and Nomenclature of Viruses. Seventh Report of the International Committee on Taxonomy of Viruses . pp  214–216 London: Academic Press;
    [Google Scholar]
  58. Wheat R. L., Clark P. Y., Brown M. G. 2003; Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. J Virol Methods 112:107–113 [CrossRef]
    [Google Scholar]
  59. Xu J., Lyons P. A., Carter M. D., Booth T. W., Davis-Poynter N. J., Shellam G. R., Scalzo A. A. 1996; Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J Gen Virol 77:49–59 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81583-0
Loading
/content/journal/jgv/10.1099/vir.0.81583-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error